Bluejay Diagnostics Inc. (NASDAQ:BJDX), a medical diagnostics company focused on near-patient testing for critical care, announced a strategic partnership with Argonaut Manufacturing Services to support the advancement of Bluejay’s Symphony platform.
Shares of Bluejay surged more than 200% in premarket trading Tuesday following the announcement.
Something went wrong.
Bluejay Focuses On Rapid Sepsis Testing Technology
The medical diagnostics company is using its Symphony System, a cost-effective, rapid, near-patient testing system for sepsis triage and monitoring of disease progression.
